Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Handset Expert (HE) is a company on a mission to help a customer select his/her next phone or SIM card in a quick, cost-effective, and easy manner. HE claims to provide all the information customers need when buying a new phone and/or SIM and streamline every step of the process. In 2018, 28.8 million handsets were sold in the UK. 61% of consumers expect to buy a new phone in the next two years, and the advent of 5G will usher a new generation of devices. The company, having undergone a thorough test and build phase, believes that it is in a suitable position for a full launch with a comprehensive go-to-market plan in place. It has featured in publications such as The Guardian, The Sun and The Mirror, been recommended by MoneySavingExpert and received Ofcom accreditation. It will use the investment to grow its business across different verticals to become the UK’s go-to mobile recommendation service.
days to go:
Expired
investment:
£286,670
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go:
Expired
investment:
£165,627
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
Colltec Laboratories are aiming to create the most effective skincare products. They have just released a new product called Ingenious Beauty that is clinically proven to reduce fine lines by 26%.
days to go:
Expired
investment:
£3,580
Friction Free Shaving are a UK subscription based razor delivery service designed soley for women. Each month they deliver a razor or replacement blades right to your door so you don't even need to leave the house.
days to go:
Expired
investment:
£150,522
A high-end audio equipment business designing, engineering and manufacturing every product in the UK. Kleio Audio's amplifiers are made from aluminium blocks, which are machined individually and assembled by hand to produce a powerful and energy-efficient product.
At a UK audio show, Kleio Audio launched two K1 products that attracted the attention of a retailer who have decided to stock the company’s goods on their platform. Kleio Audio has also received attention through major publications such as What Hi-Fi, as well as receive international press in the Netherlands, Norway and Russia.
Kleio Audio aims to grow the brand further by manufacturing various types of audio equipment to satisfy customer demand, as well as increase the number of retailer relations. Regional sales personnel and distributors will manage international sales of goods manufactured by the company.
days to go:
Expired
investment:
£14,300
